Antiemetic activity of megestrol acetate in patients receiving chemotherapy

[1] Schnell FM(2003)Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control Oncologist 8 187-198

[2] Glaus A(2004)Chemotherapy-induced nausea and vomiting in routine practice: a European perspective Support Care Cancer 12 708-715

[3] Knipping C(1997)Proposal for classifying the acute emetogenicity of cancer chemotherapy J Clin Oncol 15 103-109

[4] Morant R(1997)Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group Support Care Cancer 5 307-313

[5] Hesketh PJ(2004)Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer J 100 2261-2268

[6] Kris MG(1991)Controlling emesis in patients receiving cancer chemotherapy Recent Results Cancer Res 121 68-85

[7] Grunberg SM(1987)The management of chemotherapy-induced nausea and vomiting Med Clin N Am 71 289-301

[8] Osoba D(2006)American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2932-2947

[9] Zee B(2006)Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference Ann Oncol 17 20-28

[10] Warr D(2002)Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes J Clin Oncol 20 2805-2811

[1] Schnell FM(2003)Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control Oncologist 8 187-198

[2] Glaus A(2004)Chemotherapy-induced nausea and vomiting in routine practice: a European perspective Support Care Cancer 12 708-715

[3] Knipping C(1997)Proposal for classifying the acute emetogenicity of cancer chemotherapy J Clin Oncol 15 103-109

[4] Morant R(1997)Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group Support Care Cancer 5 307-313

[5] Hesketh PJ(2004)Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer J 100 2261-2268

[6] Kris MG(1991)Controlling emesis in patients receiving cancer chemotherapy Recent Results Cancer Res 121 68-85

[7] Grunberg SM(1987)The management of chemotherapy-induced nausea and vomiting Med Clin N Am 71 289-301

[8] Osoba D(2006)American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2932-2947

[9] Zee B(2006)Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference Ann Oncol 17 20-28

[10] Warr D(2002)Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes J Clin Oncol 20 2805-2811